Biobot Surgical’s cover photo
Biobot Surgical

Biobot Surgical

Medical Device

First- and best-in-class robotic prostate biopsy and treatment solutions.

About us

At Biobot Surgical, our mission is to revolutionize the realm of robotic-assisted biopsy and treatment for prostate cancer. As the landscape for prostate cancer treatment evolves, we aren’t just riding this wave of change — we’re propelling it, ushering in a new era of excellence in prostate disease management. At the forefront of these advances in the standard of care in prostate cancer management, we are poised to address the global unmet need for a precise approach to transperineal procedures — and make a monumental impact on the lives of patients. Our first- and best-in-class surgical robot iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), the US (FDA), Australia (TGA), and Singapore (HSA), and is being used in some of the most prestigious hospitals around the world. We remain committed to advancing innovation in the field of robotic-assisted transperineal biopsy and treatment, and delivering the precision urologists require—and patients deserve.

Industry
Medical Device
Company size
11-50 employees
Headquarters
Singapore
Type
Privately Held
Founded
2007
Specialties
Urology, Prostate Cancer, Robotic Surgery, minimally-invasive, Prostate Biopsy, and Prostate Diagnosis

Locations

Employees at Biobot Surgical

Updates

  • Biobot Surgical reposted this

    View profile for Tina Xavy

    Product Marketing II Medical Affairs || Clinical Affairs || Market Access || Clinical Evaluation Plan || CER || Post Market Surveillance || PMCF ||PSUR || Real World Evidence || Pharmacovigilance

    Happening today.

    View organization page for Biobot Surgical

    2,527 followers

    Precision. Expertise. Innovation. 🩺 At the 𝐒𝐈𝐔𝟐𝟎𝟐𝟓 𝐌𝐑𝐈-𝐔𝐒 𝐅𝐮𝐬𝐢𝐨𝐧 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩 on 𝟑𝟏𝐬𝐭 𝐎𝐜𝐭𝐨𝐛𝐞𝐫r, delegates will have an opportunity to experience the 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 𝐬𝐲𝐬𝐭𝐞𝐦 in action. Prof. Dr. Christian Wetterauer and A/Prof Devang Desai, leading experts in prostate biopsy, will guide participants through a 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 demonstrating the Mona Lisa workflow—showcasing its:  High precision targeting of suspicious lesions  Integrated systematic and targeted core planning  Consistent operator-independent performance  Streamlined robotic workflow for efficient, safe biopsies Learn directly from the experts and see how the Mona Lisa system can elevate 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞 and 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐚𝐥 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲. #SIU2025 #ProstateBiopsy #MonaLisaSystem #PrecisionMatters #MedicalInnovation #HandsOnLearning

    • No alternative text description for this image
  • Biobot Surgical reposted this

    The Aquilant team is delighted to be supporting the 45th Société Internationale d'Urologie (SIU) in Edinburgh this week, alongside our partners Biobot Surgical and AngioDynamics International.   We will be showcasing the #MonaLisa 2.0 robotic platform for transperineal biopsy and ablation procedures, together with the #NanoKnife IRE system for the treatment of intermediate-risk prostate cancer — demonstrating how robotic precision enables accurate needle placement for focal prostate ablation.   The Mona Lisa 2.0 will also feature in the hands-on workshops, with Prof. Dr. Christian Wetterauer and A/Prof Devang Desai, guiding delegates on how the Mona Lisa 2.0 can increase confidence in diagnosis and improve efficiency during procedures.   See you at stand 804.   #SIU2025 #Urology #ProstateCancer #RoboticSurgery #FocalTherapy #PrecisionThatMatters #ImprovingLives

    • No alternative text description for this image
  • Biobot Surgical reposted this

    View profile for Giansante Alessandrini

    Business Development | Customer focused | Capital Equipment | SaaS | New Product Introduction | Solutions driven | Team player | Quality always | Customer Success

    A great opportunity to hear from the experts how Mona Lisa robotic system can improve prostate biopsy!

    View organization page for Biobot Surgical

    2,527 followers

    Precision. Expertise. Innovation. 🩺 At the 𝐒𝐈𝐔𝟐𝟎𝟐𝟓 𝐌𝐑𝐈-𝐔𝐒 𝐅𝐮𝐬𝐢𝐨𝐧 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩 on 𝟑𝟏𝐬𝐭 𝐎𝐜𝐭𝐨𝐛𝐞𝐫r, delegates will have an opportunity to experience the 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 𝐬𝐲𝐬𝐭𝐞𝐦 in action. Prof. Dr. Christian Wetterauer and A/Prof Devang Desai, leading experts in prostate biopsy, will guide participants through a 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 demonstrating the Mona Lisa workflow—showcasing its:  High precision targeting of suspicious lesions  Integrated systematic and targeted core planning  Consistent operator-independent performance  Streamlined robotic workflow for efficient, safe biopsies Learn directly from the experts and see how the Mona Lisa system can elevate 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞 and 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐚𝐥 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲. #SIU2025 #ProstateBiopsy #MonaLisaSystem #PrecisionMatters #MedicalInnovation #HandsOnLearning

    • No alternative text description for this image
  • Precision. Expertise. Innovation. 🩺 At the 𝐒𝐈𝐔𝟐𝟎𝟐𝟓 𝐌𝐑𝐈-𝐔𝐒 𝐅𝐮𝐬𝐢𝐨𝐧 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩 on 𝟑𝟏𝐬𝐭 𝐎𝐜𝐭𝐨𝐛𝐞𝐫r, delegates will have an opportunity to experience the 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 𝐬𝐲𝐬𝐭𝐞𝐦 in action. Prof. Dr. Christian Wetterauer and A/Prof Devang Desai, leading experts in prostate biopsy, will guide participants through a 𝗵𝗮𝗻𝗱𝘀-𝗼𝗻 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 demonstrating the Mona Lisa workflow—showcasing its:  High precision targeting of suspicious lesions  Integrated systematic and targeted core planning  Consistent operator-independent performance  Streamlined robotic workflow for efficient, safe biopsies Learn directly from the experts and see how the Mona Lisa system can elevate 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞 and 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐚𝐥 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲. #SIU2025 #ProstateBiopsy #MonaLisaSystem #PrecisionMatters #MedicalInnovation #HandsOnLearning

    • No alternative text description for this image
  • View organization page for Biobot Surgical

    2,527 followers

    Biobot Surgical debuts in 𝐒𝐜𝐨𝐭𝐥𝐚𝐧𝐝!          Biobot Surgical marks its first appearance in Scotland at 𝐒𝐈𝐔 𝟐𝟎𝟐𝟓, together with 𝐀𝐪𝐮𝐢𝐥𝐚𝐧𝐭, at Booth #805. We’ll be showcasing the 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 𝟐.𝟎 robotic transperineal platform for transperineal 𝐛𝐢𝐨𝐩𝐬𝐲 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞 𝐚𝐧𝐝 𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞 with 𝐀𝐧𝐠𝐢𝐨𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬’ 𝐍𝐚𝐧𝐨𝐤𝐧𝐢𝐟𝐞 𝐈𝐑𝐄 𝐬𝐲𝐬𝐭𝐞𝐦 — demonstrating how 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 enables 𝐚𝐜𝐜𝐮𝐫𝐚𝐭𝐞, 𝐫𝐞𝐩𝐫𝐨𝐝𝐮𝐜𝐢𝐛𝐥𝐞 𝐧𝐞𝐞𝐝𝐥𝐞 𝐩𝐥𝐚𝐜𝐞𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐟𝐨𝐜𝐚𝐥 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧. Experience how 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐜𝐨𝐧𝐭𝐫𝐨𝐥 make every step simpler, safer, and smarter. ⚙ 𝐒𝐈𝐔 𝟐𝟎𝟐𝟓 | 𝐁𝐨𝐨𝐭𝐡 #𝟖𝟎𝟓 🧭 𝐄𝐝𝐢𝐧𝐛𝐮𝐫𝐠𝐡, 𝐒𝐜𝐨𝐭𝐥𝐚𝐧𝐝 #SIU2025 #Urology #ProstateCancer #RoboticSurgery #FocalTherapy #NanoKnife #MonaLisa #BiobotSurgical #PrecisionThatMatters

    • No alternative text description for this image
  • 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐢𝐧 𝐞𝐯𝐞𝐫𝐲 𝐏𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐛𝐢𝐨𝐩𝐬𝐲! Biobot Surgical is proud to be at 𝐊𝐔𝐀 𝟐𝟎𝟐𝟓 - 𝐁𝐨𝐨𝐭𝐡 #𝟏𝟎𝟐, together with our partner 𝐋𝐞𝐚𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, showcasing the 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐭𝐫𝐚𝐧𝐬𝐩𝐞𝐫𝐢𝐧𝐞𝐚𝐥 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐧𝐞𝐞𝐝𝐥𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐢𝐧𝐠 𝐬𝐲𝐬𝐭𝐞𝐦. Discover how 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 delivers 𝐮𝐧𝐦𝐚𝐭𝐜𝐡𝐞𝐝 𝐚𝐜𝐜𝐮𝐫𝐚𝐜𝐲, 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐜𝐲, 𝐚𝐧𝐝 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧-𝐟𝐫𝐞𝐞 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬, empowering urologists to achieve true precision in prostate cancer management. Don’t miss the chance to connect with our team and see how 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐟𝐮𝐬𝐢𝐨𝐧 𝐬𝐲𝐬𝐭𝐞𝐦 𝐛𝐫𝐢𝐧𝐠𝐬 𝐚𝐛𝐨𝐮𝐭 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐭𝐡𝐚𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐟𝐨𝐫 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐜𝐚𝐫𝐞. ⚙ KUA 2025 | Booth #102 🧭 Oct 22- 24 #KUA2025 #Urology #ProstateCancer #RoboticSurgery #MonaLisa #BiobotSurgical #PrecisionThatMatters #FusionBiopsy

    • No alternative text description for this image
  • We’re proud to share that 𝐃𝐫. 𝐓𝐬𝐚𝐧𝐠 𝐖𝐨𝐨𝐧 𝐂𝐡𝐚𝐮 from the 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥, 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞, will be leading a 𝙈𝙤𝙣𝙖 𝙇𝙞𝙨𝙖 𝙈𝙖𝙨𝙩𝙚𝙧𝙘𝙡𝙖𝙨𝙨 in 𝐒𝐞𝐨𝐮𝐥, 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚, organized by our valued distributor 𝐋𝐞𝐚𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞. 𝐃𝐫. 𝐓𝐬𝐚𝐧𝐠 brings extensive experience in robotic-assisted prostate biopsy and will share his practical insights on the 𝐢𝐒𝐑’𝐨𝐛𝐨𝐭™ 𝐌𝐨𝐧𝐚 𝐋𝐢𝐬𝐚 𝐬𝐲𝐬𝐭𝐞𝐦, covering real-world workflow integration with 𝐔𝐫𝐨𝐅𝐮𝐬𝐢𝐨𝐧 and 𝐔𝐫𝐨𝐁𝐢𝐨𝐩𝐬𝐲, followed by a hands-on demonstration session. Biobot Surgical continues to support clinicians worldwide in delivering precision and consistency in prostate biopsy through training and collaboration. 𝘚𝘦𝘰𝘶𝘭, 𝘚𝘰𝘶𝘵𝘩 𝘒𝘰𝘳𝘦𝘢 — 𝘖𝘤𝘵𝘰𝘣𝘦𝘳 21, 2025  𝘏𝘰𝘴𝘵𝘦𝘥 𝘣𝘺 𝘓𝘦𝘢𝘥 𝘏𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘒𝘰𝘳𝘦𝘢 #MonaLisa #BiobotSurgical #ProstateBiopsy #PrecisionThatMatters #Urology #ClinicalEducation #MedicalInnovation

    • No alternative text description for this image
  • This week, Biobot Surgical is heading to Focal+ 2025, happening October 9–11 in Maryland.   Visit our booth to see how the Mona Lisa 2.0 system is redefining precision in prostate disease management through robotic-controlled needle positioning and advanced 3D visualization.   With over 25,000 procedures performed globally, we’re driving better outcomes with robotic transperineal biopsy and treatment solutions.   Join us at Focal+ to explore how robotic precision is transforming prostate care. Let us know if you’ll be attending, we’d love to connect. #Focal2025 Adrian Whitford Siew Neo 梁 秀 卿 Drew Shaffer Derrick Yong Jasper Daniel

    • No alternative text description for this image
  • Unlock the future of prostate biopsy at the 𝐇𝐊𝐔𝐀 𝐌𝐚𝐬𝐭𝐞𝐫𝐜𝐥𝐚𝐬𝐬!   ✅ Master 𝐌𝐑𝐈–𝐔𝐒 𝐅𝐮𝐬𝐢𝐨𝐧 𝐑𝐨𝐛𝐨𝐭𝐢𝐜 𝐁𝐢𝐨𝐩𝐬𝐲 with Mona Lisa ✅ Learn how Mona Lisa brings 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧, 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐜𝐲, 𝐚𝐧𝐝 𝐬𝐚𝐟𝐞𝐭𝐲 to prostate cancer diagnosis ✅ Gain 𝐩𝐫𝐚𝐜𝐭𝐢𝐜𝐚𝐥 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 on performing procedures under local anesthesia (LA)    Stay ahead with the latest innovations in urology. Don’t miss this chance to elevate your skills and transform your practice.   📅 𝟑𝟎 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟓, 𝟕𝐩𝐦 (𝐆𝐌𝐓+𝟖)  𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞: https://lnkd.in/gWKuZTZt

    • No alternative text description for this image
  • View organization page for Biobot Surgical

    2,527 followers

    📅 𝐒𝐚𝐯𝐞 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞!   Join us at the 𝐇𝐊𝐔𝐀 𝐌𝐚𝐬𝐭𝐞𝐫𝐜𝐥𝐚𝐬𝐬 𝐨𝐧 𝐑𝐨𝐛𝐨𝐭𝐢𝐜 𝐓𝐫𝐚𝐧𝐬𝐩𝐞𝐫𝐢𝐧𝐞𝐚𝐥 𝐏𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐁𝐢𝐨𝐩𝐬𝐲 on 𝟑𝟎 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟓 at 𝟕𝐩𝐦 (𝐆𝐌𝐓 +𝟖)   We’re thrilled to have our expert faculty at the HKUA Masterclass: Prof. Dr. Christian Wetterauer, Chief Physician, University Hospital Basel and 𝐏𝐫𝐨𝐟. 𝐖𝐚𝐧𝐠 𝐇𝐚𝐢 𝐅𝐞𝐧𝐠, Chief Urology Surgeon, Shanghai Eastern Hospital.   They will share insights on cutting-edge transperineal robotic prostate biopsy techniques.   Seats are filling fast – don’t miss out!    Register here: https://lnkd.in/gEFiFSSn

Similar pages

Funding

Biobot Surgical 3 total rounds

Last Round

Series unknown

US$ 8.5M

See more info on crunchbase